Mr. McCarrey has more than 15 years of experience in medical device sales. He recently served as the executive vice president of North American cardiovascular sales for Bayer International.
AxoGen, a medical device company with a focus on peripheral nerve repair, is trying to shift its focus from early adoption to broad usage in surgical nerve repair, according to the release. Mr. McCarrey will work to increase sales and implement strategic growth initiatives.
More Articles on Devices:
Lanx Releases ALTA Cervical Spine Fusion Device
TranS1 Acquires Baxano Spine Device Manufacturer at $23.6M
12 News Updates for Orthopedic & Spine Device Companies
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
